Abraxane paclitaxel plus albumin regulatory update

FDA accepted for filing an NDA from APPX for Abraxane to treat metastatic breast cancer. Abraxane is a nanoparticle comprising paclitaxel bound to albumin that avoids the use of solvents with paclitax...